SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-23-033305
Filing Date
2023-03-16
Accepted
2023-03-16 16:05:56
Documents
4
Group Members
D. E. SHAW & CO., L.L.C.D. E. SHAW VALENCE PORTFOLIOS, L.L.C.DAVID E. SHAW

Document Format Files

Seq Description Document Type Size
1 SC 13G tm239764d1_sc13g.htm SC 13G 70637
2 EXHIBIT 1 tm239764d1_ex1.htm EX-99.1 5883
3 EXHIBIT 2 tm239764d1_ex2.htm EX-99.2 5928
4 EXHIBIT 3 tm239764d1_ex3.htm EX-99.3 5884
  Complete submission text file 0001104659-23-033305.txt   90076
Mailing Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036
Business Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036 2124780000
D. E. SHAW & CO, L.P. (Filed by) CIK: 0001009268 (see all company filings)

IRS No.: 133695715 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma Inc. (Subject) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92634 | Film No.: 23738774
SIC: 2836 Biological Products, (No Diagnostic Substances)